Abstract
Increased risk of developing metabolic syndrome (MetS) has been associated with the circadian clock genes. In this study, we assessed whether 29 circadian clock-related genes (including ADCYAP1, ARNTL, ARNTL2, BHLHE40, CLOCK, CRY1, CRY2, CSNK1D, CSNK1E, GSK3B, HCRTR2, KLF10, NFIL3, NPAS2, NR1D1, NR1D2, PER1, PER2, PER3, REV1, RORA, RORB, RORC, SENP3, SERPINE1, TIMELESS, TIPIN, VIP, and VIPR2) are associated with MetS and its individual components independently and/or through complex interactions in a Taiwanese population. We also analyzed the interactions between environmental factors and these genes in influencing MetS and its individual components. A total of 3,000 Taiwanese subjects from the Taiwan Biobank were assessed in this study. Metabolic traits such as waist circumference, triglyceride, high-density lipoprotein cholesterol, systolic and diastolic blood pressure, and fasting glucose were measured. Our data showed a nominal association of MetS with several single nucleotide polymorphisms (SNPs) in five key circadian clock genes including ARNTL, GSK3B, PER3, RORA, and RORB; but none of these SNPs persisted significantly after performing Bonferroni correction. Moreover, we identified the effect of GSK3B rs2199503 on high fasting glucose (P = 0.0002). Additionally, we found interactions among the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 SNPs influenced MetS (P < 0.001 ~ P = 0.002). Finally, we investigated the influence of interactions between ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, and RORB rs972902 with environmental factors such as alcohol consumption, smoking status, and physical activity on MetS and its individual components (P < 0.001 ~ P = 0.002). Our study indicates that circadian clock genes such as ARNTL, GSK3B, PER3, RORA, and RORB genes may contribute to the risk of MetS independently as well as through gene-gene and gene-environment interactions.
Introduction
Circadian rhythms are naturally recurring cycles that regulate the timing of biological events such as the sleep-wake cycle and energy metabolism [1]. The intracellular molecular machinery underlying circadian rhythms implicates that circadian oscillations are controlled and maintained by a set of core circadian clock genes, including the aryl hydrocarbon receptor nuclear translocator like (ARNTL), clock circadian regulator (CLOCK), cryptochrome circadian clock 1 (CRY1), cryptochrome circadian clock 2 (CRY2), neuronal PAS domain protein 2 (NPAS2), period circadian clock 1 (PER1), period circadian clock 2 (PER2), and period circadian clock 3 (PER3) genes [2]. The circadian clock genes are prominently involved in the regulation of metabolism and energy homeostasis because circadian rhythms in turn impact on metabolic activity and metabolism [3]. Circadian disruptions have been well documented in adverse effects on human health, influencing lipid and glucose homeostasis, inflammation, and cardiovascular functions [4].
Accumulating evidence indicates that the circadian clock genes may contribute to the development of metabolic syndrome (MetS). Animal studies showed that a loss-of-function mutation of the circadian clock genes, such as Clock and Arntl, may result in metabolic abnormalities of lipid and glucose homeostasis, hallmarks of MetS [5, 6]. In humans, evidence has been reported for a potential association of MetS with the CLOCK [7] and CRY2 [8] genes. Previously, Scott et al. showed that a three-marker haplotype (rs4864548, rs3736544, and rs1801260) of the CLOCK gene was associated with MetS, although there were no significant associations between any of these three SNPs and MetS individually [7]. Additionally, Kovanen et al. indicated that CRY2 rs75065406 had a nominally significant association with MetS, but this association did not remain significant after correcting for multiple testing [8]. Moreover, circadian clock genes have been shown to link with the individual components of MetS. Woon et al. found that a three-marker haplotype (rs6486121, rs3789327, and rs969485) of the ARNTL gene was associated with hypertension, an individual component of MetS [9]. Further, Englund et al. reported that NPAS2 rs11541353 was associated with hypertension and PER2 #10870 was linked to blood glucose levels [10]. Kovanen et al. also indicated a nominally significant association of elevated blood pressure with the CRY1 haplotype (rs4964513 and rs12821586); however, the significance did not persist after adjusting for multiple testing [8]. In addition, it has been suggested that circadian clock genes such as ARNTL, CRY1, and PER2 are expressed in human adipose tissue, and their gene expressions were related to the individual components of MetS such as waist circumference [11]. Furthermore, several animal studies indicated that metabolic complications such as MetS, dyslipidemia, glucose intolerance, hypoinsulinaemia, and diabetes can result from deletion of the Arntl, Clock, or Per3 genes, suggesting miscommunication between the circadian clock and metabolic pathways may lead to metabolic disorders [12–14].
While there have been several studies examining the relationship between single nucleotide polymorphisms (SNPs) in the circadian clock genes and MetS, to our knowledge, none have been evaluated in terms of gene-gene interactions. Furthermore, the interplay between the circadian clock genes and health-related behaviors, such as alcohol consumption, smoking status, and physical activity, has not been fully assessed in previous association studies. Given that gene-gene and gene-environment interactions may play a pivotal role in the development of MetS, we hypothesized that the circadian clock genes may contribute to the etiology of MetS and its individual components independently and/or through complex interactions. The gene panel consisted of 29 circadian clock-relevant genes (S1 Table) selected from the literature [7–11,15–21], including the adenylate cyclase activating polypeptide 1 (ADCYAP1), ARNTL, ARNTL2, basic helix-loop-helix family member e40 (BHLHE40), CLOCK, CRY1, CRY2, casein kinase 1 delta (CSNK1D), casein kinase 1 epsilon (CSNK1E), glycogen synthase kinase 3 beta (GSK3B), hypocretin receptor 2 (HCRTR2), Kruppel like factor 10 (KLF10), nuclear factor interleukin 3 regulated (NFIL3), NPAS2, nuclear receptor subfamily 1 group D member 1 (NR1D1), nuclear receptor subfamily 1 group D member 2 (NR1D2), PER1, PER2, PER3, REV1 DNA directed polymerase (REV1), RAR related orphan receptor A (RORA), RAR related orphan receptor B (RORB), RAR related orphan receptor C (RORC), SMT3 specific peptidase 3 (SENP3), serpin family E member 1 (SERPINE1), timeless circadian clock (TIMELESS), TIMELESS interacting protein (TIPIN), vasoactive intestinal peptide (VIP), and vasoactive intestinal peptide receptor 2 (VIPR2) genes.
Materials and methods
Study population
This study incorporated Taiwanese subjects from the Taiwan Biobank, which gathered information and specimens from participants in recruitment centers across Taiwan in 2013–2015 [22–27]. The Taiwan Biobank was mainly funded by the Taiwan government and aimed to facilitate collaboration for public health-related research concerning local common chronic diseases [22]. The study cohort consisted of 3,000 participants. Inclusion criteria were individuals who were aged 30 years or over and were self-reported as being of Taiwanese Han Chinese ancestry [24]. Participants with a history of cancer were excluded [24]. Ethical approval for the study was granted by the Institutional Review Board of the Taiwan Biobank before conducting the study (approval number: 201506095RINC). Each subject signed the approved informed consent form. All experiments were performed in accordance with relevant guidelines and regulations.
Current alcohol drinkers were defined as persons who reported drinking more than 150 ml of alcohol per week during the last six months [23]. Current smokers were defined as persons who reported smoking every day or some days during the last six months [23]. Physical activity was defined by the amount of excise activity for more than three times and more than 30 minutes each time in each week.
Metabolic syndrome
Measurements of metabolic traits (including as waist circumference, triglyceride, high-density lipoprotein cholesterol, systolic and diastolic blood pressure, and fasting glucose) were obtained when participants underwent general health examinations [22–24]. To assess MetS, we used the International Diabetes Federation (IDF) definition, which requires that the participant represented by central obesity (defined as waist circumference ≥ 90 cm in male subjects and ≥ 80 cm in female subjects) plus the presence of two or more of the following four components: (1) triglycerides ≥ 150 mg/dl; (2) HDL cholesterol < 40 mg/dl in male subjects and < 50 mg/dl in female subjects; (3) systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg; and (4) fasting plasma glucose ≥ 100 mg/dl [28]. Blood pressure was based on the average of two measurements.
Genotyping
DNA was isolated from blood samples using a QIAamp DNA blood kit following the manufacturer’s instructions (Qiagen, Valencia, CA, USA). The quality of the isolated genomic DNA was evaluated using agarose gel electrophoresis, and the quantity was determined by spectrophotometry [29]. SNP genotyping was carried out using the custom Taiwan BioBank chips and run on the Axiom Genome-Wide Array Plate System (Affymetrix, Santa Clara, CA, USA). To efficiently obtain maximal genetic information from Taiwanese Han Chinese samples, the custom Taiwan BioBank chips were designed by using SNPs on the Axiom Genome-Wide CHB 1 Array (Affymetrix, Inc., Santa Clara, CA, USA) with minor allele frequencies (MAFs) ≥ 5%, by using SNPs in exons with MAFs > 10% on the Human Exome BeadChip (Illumina, Inc., San Diego, CA, USA), and by using SNPs previously reported in ancestry information panels, cancer studies, and pharmacogenetic studies. [24]. In this study, the SNP panel consisted of variants from the following 29 circadian clock genes: ADCYAP1, ARNTL, ARNTL2, BHLHE40, CLOCK, CRY1, CRY2, CSNK1D, CSNK1E, GSK3B, HCRTR2, KLF10, NFIL3, NPAS2, NR1D1, NR1D2, PER1, PER2, PER3, REV1, RORA, RORB, RORC, SENP3, SERPINE1, TIMELESS, TIPIN, VIP, and VIPR2.
Statistical analysis
Categorical data were evaluated using the chi-square test. We conducted the Student’s t test to compare the difference in the means from two continuous variables. To estimate the association of the investigated SNP with MetS, we conducted a logistic regression analysis to evaluate the odds ratios (ORs) and their 95% confidence intervals (CIs), adjusting for covariates including age and gender [30]. Furthermore, we estimated the association of the investigated SNP with individual components of MetS by using logistic regression analysis, adjusting for age and gender [31]. The genotype frequencies were assessed for Hardy-Weinberg equilibrium using a χ2 goodness-of-fit test with 1 degree of freedom (i.e. the number of genotypes minus the number of alleles). Multiple testing was adjusted by the Bonferroni correction. To address the issue of multiple testing, we also calculated Q values and false discovery rates (FDRs) using the qvalue function in an R package [32]. The criterion for significance was set at P < 0.05 for all tests. Data are presented as the mean ± standard deviation.
To investigate gene-gene and gene-environment interactions, we employed the generalized multifactor dimensionality reduction (GMDR) method [33]. We tested two-way up to four-way interactions using 10-fold cross-validation. The GMDR software provides some output parameters, including the testing accuracy and empirical P values, to assess each selected interaction. Moreover, we provided age and gender as covariates for gene-gene and gene-environment interaction models in our interaction analyses. Permutation testing obtains empirical P values of prediction accuracy as a benchmark based on 1,000 shuffles. In order to correct for multiple testing, we applied a conservative Bonferroni correction factor for the number of tests employed in the GMDR analysis.
Based on the effect sizes in this study, the power to detect significant associations was evaluated by QUANTO software (http://biostats.usc.edu/Quanto.html).
Results
Table 1 describes the demographic and clinical characteristics of the study population, including 533 MetS subjects and 2,467 non-MetS subjects. The MetS prevalence in our cohort was 17.8%. As shown in Table 1, the distribution was well matched for gender, but not for age. Moreover, there was a significant difference in waist circumference, triglyceride, HDL, systolic blood pressure, diastolic blood pressure, and fasting glucose between the MetS and non-MetS subjects (Table 1; all P < 0.0001, respectively). Furthermore, there was a significant difference in current alcohol consumption (P = 0.029) and smoking status (P = 0.001) between the MetS and non-MetS subjects. However, no significant difference was found between participants with and without the MetS in level of physical activity.
Table 1. Demographic and clinical characteristics of study subjects.
Characteristic | MetS | No MetS | P value |
---|---|---|---|
No. of subjects (n) | 533 | 2467 | |
Age (years) | 53.3±10.1 | 48.3±10.9 | < 0.0001 |
Gender (Male %) | 48.2% | 46.1% | 0.371 |
Waist circumference (cm) | 94.0±8.8 | 82.3±8.8 | < 0.0001 |
Triglyceride (mg/dl) | 196.7±142.3 | 99.6±57.2 | < 0.0001 |
HDL (mg/dl) | 43.8±9.2 | 55.9±12.9 | < 0.0001 |
Systolic blood pressure (mmHg) | 126.9±17.8 | 112.8±15.6 | < 0.0001 |
Diastolic blood pressure (mmHg) | 77.3±11.0 | 70.2±10.3 | < 0.0001 |
Fasting glucose (mg/dl) | 114.3±35.4 | 93.8±15.4 | < 0.0001 |
Physical activity (%) | 57.9% | 58.8% | 0.733 |
Current smoker (%) | 14.6% | 9.8% | 0.001 |
Current alcohol drinker (%) | 9.8% | 7.0% | 0.029 |
HDL = high-density lipoprotein cholesterol, MetS = metabolic syndrome, SD = standard deviation. Data are presented as mean ± standard deviation.
Among the 881 SNPs assessed in this study (S1 Table), there were 88 SNPs in the 13 circadian clock genes showing an evidence of association (P < 0.05) with MetS as shown in S2 Table. However, none of the SNPs were significantly associated with MetS after Bonferroni correction (P < 0.05/881 = 6 x 10−5). The related Q values and FDRs were listed in S3 Table. Then, we identified a nominal association (P < 0.01) of MetS with 16 SNPs, including ARNTL rs10832020, GSK3B rs2199503, PER3 (rs10746473, rs2797685, rs1689904, rs1773138), RORA (rs17237367, rs58469372, rs12591650, rs12594188, rs17270446, rs11630062, rs8029848, rs8034880, rs72752802), and RORB rs972902 (Table 2). For further investigating in the subsequent analyses, the five key SNPs in the five circadian clock genes were selected by using the best SNP from each gene, including ARNTL rs10832020 (P = 0.0065), GSK3B rs2199503 (P = 0.007), PER3 rs10746473 (P = 0.001), RORA rs8034880 (P = 0.0002), and RORB rs972902 (P = 0.0087). In addition, the genotype frequency distributions for the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 SNPs were in accordance with the Hardy–Weinberg equilibrium among the subjects (P = 0.261, 0.35, 0.253, 0.76, and 0.594, respectively).
Table 2. Odds ratio analysis with odds ratios after adjustment for covariates (including age and gender) between the MetS and 16 SNPs in five selective circadian clock genes, which have nominal evidence of association (P < 0.01).
Additive model | Dominant model | Recessive model | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | SNP | Alleles | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
ARNTL | rs10832020 | C | T | 1.23 | 1.05–1.45 | 0.0114 | 1.06 | 0.87–1.28 | 0.5586 | 1.54 | 1.13–2.09 | 0.0065 |
GSK3B | rs2199503 | T | C | 0.83 | 0.70–0.99 | 0.0331 | 1.04 | 0.85–1.26 | 0.7245 | 0.64 | 0.47–0.89 | 0.0070 |
PER3 | rs10746473 | G | A | 1.20 | 1.04–1.38 | 0.0116 | 1.46 | 1.17–1.83 | 0.0010 | 1.11 | 0.88–1.40 | 0.3691 |
rs2797685 | C | T | 1.17 | 1.01–1.35 | 0.0314 | 1.41 | 1.11–1.78 | 0.0047 | 1.07 | 0.85–1.33 | 0.5731 | |
rs1689904 | C | T | 1.16 | 1.01–1.34 | 0.0352 | 1.39 | 1.10–1.76 | 0.0061 | 1.07 | 0.86–1.33 | 0.5618 | |
rs1773138 | T | C | 0.85 | 0.74–0.99 | 0.0304 | 0.94 | 0.76–1.17 | 0.5902 | 0.71 | 0.56–0.90 | 0.0043 | |
RORA | rs17237367 | A | G | 0.82 | 0.68–0.98 | 0.0263 | 0.75 | 0.62–0.91 | 0.0036 | 0.74 | 0.53–1.05 | 0.0926 |
rs58469372 | A | G | 0.82 | 0.71–0.95 | 0.0092 | 0.85 | 0.70–1.04 | 0.1113 | 0.71 | 0.54–0.93 | 0.0129 | |
rs12591650 | A | G | 1.20 | 1.04–1.38 | 0.0109 | 1.39 | 1.11–1.75 | 0.0049 | 1.16 | 0.93–1.44 | 0.1948 | |
rs12594188 | C | T | 1.21 | 1.01–1.45 | 0.0389 | 1.33 | 1.10–1.61 | 0.0035 | 1.32 | 0.92–1.88 | 0.1272 | |
rs17270446 | G | C | 0.97 | 0.70–1.35 | 0.8455 | 1.37 | 1.12–1.68 | 0.0021 | 0.84 | 0.44–1.63 | 0.6109 | |
rs11630062 | C | T | 0.92 | 0.80–1.05 | 0.2267 | 0.76 | 0.62–0.93 | 0.0082 | 1.02 | 0.80–1.30 | 0.8834 | |
rs8029848 | G | A | 1.28 | 1.05–1.56 | 0.0127 | 1.41 | 1.17–1.71 | 0.0004 | 1.43 | 0.98–2.09 | 0.0629 | |
rs8034880 | G | A | 1.29 | 1.05–1.58 | 0.0150 | 1.44 | 1.19–1.74 | 0.0002 | 1.44 | 0.97–2.14 | 0.0711 | |
rs72752802 | C | A | 0.81 | 0.69–0.94 | 0.0053 | 0.87 | 0.72–1.06 | 0.1716 | 0.67 | 0.50–0.88 | 0.0045 | |
RORB | rs972902 | A | G | 0.72 | 0.55–0.96 | 0.0227 | 0.76 | 0.62–0.93 | 0.0087 | 0.57 | 0.33–0.98 | 0.0426 |
CI = confidence interval, MetS = metabolic syndrome, OR = odds ratio. Analysis was obtained after adjustment for covariates including age and gender. P values of < 0.01 are shown in bold.
Moreover, the OR analysis showed risk genotypes of variants of ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 after adjusting for covariates, indicating an increased MetS risk among the subjects (Table 2). As demonstrated in Table 2 for the RORA rs8034880 SNP, there was an indication of an increased MetS risk among the MetS and non-MetS subjects after adjustment of covariates such as age and gender for genetic models, including the dominant model (OR = 1.44; 95% CI = 1.19–1.74; P = 0.0002). Similarly, there was an indication of an increased risk of MetS among the subjects after adjustment of covariates for genetic models in the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, and RORB rs972902 SNPs (Table 2).
Next, Table 3 and S4 Table show the OR analysis of the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 SNPs with the individual components of MetS including (a) high waist circumference vs. normal waist circumference subjects; (b) high triglyceride vs. normal triglyceride subjects; (c) low HDL vs. normal HDL subjects; (d) high blood pressure vs. normal blood pressure subjects; and (e) high fasting glucose vs. normal fasting glucose subjects. As shown in Table 3 for the GSK3B rs2199503 (P = 0.0002), RORA rs8034880 (P = 0.02), and RORB rs972902 (P = 0.015) SNPs, there was an indication of an increased risk of high fasting glucose among the subjects after adjustment of covariates for genetic models. The effect of GSK3B rs2199503 on high fasting glucose remained significant after Bonferroni correction (P < 0.05/75 = 0.0007). Additionally, there was a significantly increased risk of high waist circumference (P = 0.0013) among the subjects for PER3 rs10746473; however, this association did not persist after Bonferroni correction (P < 0.05/75 = 0.0007).
Table 3. Odds ratio analysis with odds ratios after adjustment for covariates between individual components of the MetS and five key SNPs in the five circadian clock genes (including ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902).
Individual components of the MetS | Additive model | Recessive model | Dominant model | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
(1) ARNTL rs10832020 | |||||||||
High waist circumferencea | 1.10 | 0.96–1.26 | 0.1710 | 1.27 | 0.97–1.65 | 0.0781 | 0.95 | 0.82–1.10 | 0.5051 |
High triglycerideb | 1.04 | 0.88–1.22 | 0.6536 | 1.11 | 0.82–1.52 | 0.4951 | 0.95 | 0.80–1.14 | 0.6016 |
Low HDLc | 1.13 | 0.97–1.32 | 0.1060 | 1.29 | 0.97–1.73 | 0.0827 | 1.03 | 0.87–1.22 | 0.7361 |
High blood pressured | 1.04 | 0.88–1.22 | 0.6578 | 1.06 | 0.77–1.44 | 0.7394 | 1.05 | 0.88–1.26 | 0.5973 |
High fasting glucosee | 1.09 | 0.93–1.28 | 0.2637 | 1.15 | 0.85–1.55 | 0.3694 | 1.11 | 0.93–1.32 | 0.2518 |
(2) GSK3B rs2199503 | |||||||||
High waist circumferencea | 1.08 | 0.96–1.22 | 0.1957 | 1.13 | 0.91–1.41 | 0.2726 | 1.08 | 0.93–1.26 | 0.2908 |
High triglycerideb | 1.00 | 0.86–1.15 | 0.9832 | 0.98 | 0.75–1.28 | 0.8713 | 1.03 | 0.86–1.24 | 0.7717 |
Low HDLc | 0.99 | 0.86–1.14 | 0.9189 | 0.89 | 0.69–1.15 | 0.3697 | 1.16 | 0.97–1.38 | 0.0966 |
High blood pressured | 0.97 | 0.83–1.12 | 0.6378 | 0.94 | 0.71–1.23 | 0.6489 | 0.98 | 0.81–1.17 | 0.7933 |
High fasting glucosee | 0.75 | 0.64–0.87 | 0.0002 | 0.58 | 0.43–0.78 | 0.0003 | 0.84 | 0.70–1.00 | 0.0514 |
(3) PER3 rs10746473 | |||||||||
High waist circumferencea | 1.19 | 1.07–1.32 | 0.0018 | 1.20 | 1.00–1.44 | 0.0466 | 1.31 | 1.11–1.55 | 0.0013 |
High triglycerideb | 0.99 | 0.87–1.13 | 0.8394 | 0.92 | 0.74–1.15 | 0.4812 | 1.05 | 0.86–1.29 | 0.6252 |
Low HDLc | 1.14 | 1.01–1.29 | 0.0354 | 1.14 | 0.93–1.40 | 0.2046 | 1.24 | 1.03–1.51 | 0.0266 |
High blood pressured | 1.11 | 0.97–1.26 | 0.1317 | 1.11 | 0.90–1.38 | 0.3315 | 1.17 | 0.96–1.44 | 0.1283 |
High fasting glucosee | 0.95 | 0.84–1.09 | 0.4602 | 0.80 | 0.64–1.00 | 0.0453 | 1.12 | 0.92–1.36 | 0.2613 |
(4) RORA rs8034880 | |||||||||
High waist circumferencea | 1.04 | 0.88–1.23 | 0.6372 | 1.02 | 0.73–1.42 | 0.9029 | 1.16 | 1.00–1.35 | 0.0492 |
High triglycerideb | 1.09 | 0.89–1.32 | 0.4231 | 1.14 | 0.77–1.69 | 0.5084 | 1.10 | 0.91–1.31 | 0.3284 |
Low HDLc | 1.14 | 0.94–1.37 | 0.1781 | 1.27 | 0.88–1.82 | 0.2014 | 1.08 | 0.91–1.28 | 0.4034 |
High blood pressured | 1.19 | 0.97–1.45 | 0.0877 | 1.33 | 0.90–1.96 | 0.1515 | 1.20 | 1.00–1.44 | 0.0525 |
High fasting glucosee | 1.02 | 0.83–1.25 | 0.8581 | 0.95 | 0.63–1.42 | 0.7908 | 1.23 | 1.03–1.47 | 0.0200 |
(5) RORB rs972902 | |||||||||
High waist circumferencea | 1.03 | 0.86–1.23 | 0.7766 | 1.08 | 0.76–1.53 | 0.6667 | 0.94 | 0.81–1.10 | 0.4478 |
High triglycerideb | 0.88 | 0.70–1.11 | 0.2955 | 0.83 | 0.53–1.31 | 0.4277 | 0.83 | 0.68–1.00 | 0.0463 |
Low HDLc | 0.88 | 0.71–1.09 | 0.2494 | 0.80 | 0.52–1.22 | 0.3014 | 0.90 | 0.76–1.08 | 0.2506 |
High blood pressured | 0.81 | 0.63–1.04 | 0.0958 | 0.63 | 0.39–1.03 | 0.0648 | 1.06 | 0.88–1.28 | 0.5278 |
High fasting glucosee | 0.74 | 0.57–0.94 | 0.0150 | 0.55 | 0.34–0.90 | 0.0174 | 0.89 | 0.74–1.07 | 0.2239 |
CI = confidence interval, HDL = high-density lipoprotein cholesterol, MetS = metabolic syndrome, OR = odds ratio. Analysis was obtained after adjustment for covariates including age and gender. P values of < 0.0007 (Bonferroni correction: 0.05/75) are shown in bold.
a Waist circumference ≥ 90 cm in male subjects, waist circumference ≥ 80 cm in female subjects.
b Triglyceride ≥ 150 mg/dl.
c HDL< 40 mg/dl in male subjects, HDL < 50 mg/dl in female subjects.
d Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg.
e Fasting glucose ≥ 100 mg/dl.
In addition, the GMDR analysis was used to assess the impacts of combinations between the five SNPs in MetS and its individual components including age and gender as covariates. Table 4 and S5 Table summarize the results obtained from GMDR analysis for two-way gene-gene interaction models in influencing MetS with covariate adjustment. As shown in Table 4, there was a significant two-way model involving ARNTL rs10832020 and RORA rs8034880 (P < 0.001), GSK3B rs2199503 and RORA rs8034880 (P < 0.001), GSK3B rs2199503 and RORB rs972902 (P = 0.002), PER3 rs10746473 and RORA rs8034880 (P < 0.001), and PER3 rs10746473 and RORB rs972902 (P < 0.001). The effects of these two-way models remained significant after Bonferroni correction (P < 0.05/10 = 0.005), indicating a potential gene-gene interaction between RORA and ARNTL, between RORA and GSK3B, between RORA and PER3, between RORB and GSK3B, and between RORB and PER3 in influencing MetS. Similarly, there were two-way gene-gene interaction models in influencing individual components such as high waist circumference (P = 0.003) or high fasting glucose (P = 0.007) as shown in S6 Table. There were also a three-way model (P = 0.003) in influencing MetS and a four-way model (P = 0.004) in influencing low HDL (S6 Table). However, the effects for these models did not persist after Bonferroni correction (P < 0.05/18 = 0.0028).
Table 4. Two-way gene-gene interaction models by using the GMDR method with adjustment for age and gender.
Phenotype | Two-way interaction model | Testing accuracy (%) | P value |
---|---|---|---|
MetS | ARNTL rs10832020, GSK3B rs2199503 | 52.92 | 0.039 |
ARNTL rs10832020, PER3 rs10746473 | 53.33 | 0.021 | |
ARNTL rs10832020, RORA rs8034880 | 55.01 | < 0.001 | |
ARNTL rs10832020, RORB rs972902 | 52.92 | 0.032 | |
GSK3B rs2199503, PER3 rs10746473 | 53.15 | 0.027 | |
GSK3B rs2199503, RORA rs8034880 | 55.09 | < 0.001 | |
GSK3B rs2199503, RORB rs972902 | 54.04 | 0.002 | |
PER3 rs10746473, RORA rs8034880 | 54.78 | < 0.001 | |
PER3 rs10746473, RORB rs972902 | 55.19 | < 0.001 | |
RORA rs8034880, RORB rs972902 | 53.96 | 0.008 |
GMDR = generalized multifactor dimensionality reduction, MetS = metabolic syndrome. P value was based on 1,000 permutations. Analysis was obtained after adjustment for covariates including age and gender. P values of < 0.005 (Bonferroni correction: 0.05/10) are shown in bold.
Furthermore, Table 5 and S7 Table show the GMDR analysis of gene-environment interaction models in MetS and its individual components using age and gender as covariates. As shown in Table 5 for MetS, there were a significant two-way model involving RORB rs972902 and smoking (P < 0.001). The effect of the two-way model remained significant after Bonferroni correction (P < 0.05/18 = 0.0028), indicating a potential gene-environment interaction between RORB and smoking in influencing MetS. Additionally, there was a significant three-way model (P = 0.001) after Bonferroni correction (P < 0.0028), indicating a potential gene-environment interaction among PER3, RORB, and smoking in influencing MetS. Similarly, there were significant two-way up to four-way gene-environment interaction models (all P < 0.001) in influencing individual components such as low HDL after Bonferroni correction (P < 0.0028). In addition, there were significant three-way and four-way models (P = 0.001 and 0.002, respectively) in influencing high fasting glucose after Bonferroni correction (P < 0.0028).
Table 5. Gene-environment interaction models identified by the GMDR method with adjustment for age and gender.
Phenotype | Best interaction model | Testing accuracy (%) | P value |
---|---|---|---|
(1) Two-way interaction models | |||
MetS | RORB rs972902, smoking | 54.33 | < 0.001 |
High waist circumferencea | ARNTL rs10832020, physical activity | 51.93 | 0.079 |
High triglycerideb | RORB rs972902, smoking | 52.17 | 0.068 |
Low HDLc | RORB rs972902, physical activity | 55.45 | < 0.001 |
High blood pressured | RORA rs8034880, physical activity | 52.75 | 0.038 |
High fasting glucosee | PER3 rs10746473, alcohol consumption | 53.57 | 0.003 |
(2) Three-way interaction models | |||
MetS | PER3 rs10746473, RORB rs972902, smoking | 55.73 | 0.001 |
High waist circumferencea | ARNTL rs10832020, PER3 rs10746473, physical activity | 52.08 | 0.063 |
High triglycerideb | ARNTL rs10832020, PER3 rs10746473, physical activity | 53.42 | 0.016 |
Low HDLc | PER3 rs10746473, smoking, physical activity | 56.11 | < 0.001 |
High blood pressured | PER3 rs10746473, RORA rs8034880, physical activity | 51.02 | 0.280 |
High fasting glucosee | ARNTL rs10832020, GSK3B rs2199503, physical activity | 54.45 | 0.001 |
(3) Four-way interaction models | |||
MetS | PER3 rs10746473, RORA rs8034880, RORB rs972902, smoking | 54.23 | 0.008 |
High waist circumferencea | ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, physical activity | 52.30 | 0.051 |
High triglycerideb | ARNTL rs10832020, PER3 rs10746473, RORA rs8034880, physical activity | 51.67 | 0.168 |
Low HDLc | GSK3B rs2199503, PER3 rs10746473, RORB rs972902, physical activity | 55.89 | < 0.001 |
High blood pressured | ARNTL rs10832020, PER3 rs10746473, RORA rs8034880, physical activity | 51.28 | 0.221 |
High fasting glucosee | ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, physical activity | 54.50 | 0.002 |
GMDR = generalized multifactor dimensionality reduction, HDL = high-density lipoprotein cholesterol, MetS = metabolic syndrome. P value was based on 1,000 permutations. Analysis was obtained after adjustment for covariates including age and gender. P values of < 0.0028 (Bonferroni correction: 0.05/18) are shown in bold.
a Waist circumference ≥ 90 cm in male subjects, waist circumference ≥ 80 cm in female subjects.
b Triglyceride ≥ 150 mg/dl.
c HDL< 40 mg/dl in male subjects, HDL < 50 mg/dl in female subjects.
d Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg.
e Fasting glucose ≥ 100 mg/dl.
Finally, statistical power analysis revealed that the present study had a 99.9% power to detect associations of ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, or RORB rs972902 with MetS among the MetS and non-MetS subjects.
Discussion
Our association study is the first to date to examine whether the main effects of 881 SNPs in 29 circadian clock-related genes are significantly associated with the risk of MetS and its individual components independently and/or through gene-gene interactions among Taiwanese individuals. We also investigated the relationship between these genes and health-related behaviors to examine whether these genes confer a risk of MetS according to its effect on gene-environment interactions. A growing body of evidence indicates that genetic association studies using individual genes may overlook the associations that can only be identified if gene-gene and gene-environment interactions are explored [34]. Therefore, we further identified five key SNPs in five circadian clock genes such as ARNTL, GSK3B, PER3, RORA, and RORB to assess gene-gene and gene-environment interactions although the association with MetS did not remain significant after performing Bonferroni correction (P < 6 x 10−5). Here, we report for the first time that gene-gene interactions of the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 SNPs may contribute to the etiology of MetS. Moreover, there were gene-environment interactions between ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, and RORB rs972902 with health-related behaviors, such as alcohol consumption, smoking status, and physical activity. Finally, our data revealed that the GSK3B rs2199503 SNP was associated with the individual component of MetS such as high fasting glucose.
Regarding the ARNTL gene, we found a positive association of MetS with 4 SNPs in the ARNTL gene, especially the rs10832020 SNP. The ARNTL gene is located on chromosome 11p15 and encodes a basic helix-loop-helix protein to build the ARNTL/CLOCK heterodimeric protein with CLOCK, another basic helix-loop-helix protein [9]. The ARNTL gene has been associated with metabolic regulation [9, 13]. Woon et al. identified a three-marker haplotype (rs6486121, rs3789327, and rs969485) of the ARNTL gene as an indicator of hypertension [9]. Moreover, Shimba et al. demonstrated that deletion of the Arntl gene induced MetS and dyslipidemia in an animal model [13]. In the present study, we detected an association of high blood pressure with ARNTL rs3789327 (P = 0.0346), but not with ARNTL rs6486121 and rs969485 (data not shown). In addition, we did not detect an association of MetS with ARNTL rs6486121, rs3789327, and rs969485 in this study.
Further, five potential candidate SNPs for MetS were identified at the GSK3B gene, particularly the rs2199503 SNP. We also suggested an association of GSK3B rs2199503 with high fasting glucose. The GSK3B gene is located on chromosome 3q13.3 and encodes a subfamily of glycogen synthase kinase (GSK), which comprises two isoforms GSK3A and GSK3B. It has been implicated that GSK3 regulates numerous cellular functions such as metabolism, circadian rhythms, neurological degeneration, and immune responses [35]. Chen et al. reported that the expression of phosphatidylinositol-3 kinase (PI3K)-dependent GSK3 stimulates the production of adiponectin and protects against diet-induced MetS in an animal study [36].
On another note, there was an association of MetS with 6 SNPs within the PER3 gene, notably the rs10746473 SNP. Our analysis also indicated that there was an association of PER3 rs10746473 with high waist circumference. The PER3 gene, located on chromosome 1p36.23, encodes components of the circadian rhythms of locomotor activity, metabolism, and feeding behavior [37]. Dallmann and Weaver reported that the Per3 mutant mice led to higher body mass on a high fat diet, suggesting Per3 may play a role in body mass regulation [38]. In addition, Costa et al. demonstrated that Per3 knock-out mice displayed glucose intolerance as well as altered body composition (such as increased adipose and decreased muscle), indicating Per3 as potent mediator of cell fate [14]. In an animal study, Pendergast et al. also showed that the function of Per3 was tissue specific such that the loss of functional PER3 had an effect on circadian period in about half of the analyzed tissues, demonstrating Per3 as an important player in the mammalian circadian system [39].
Moreover, our results are the first to raise the possibility that 43 SNPs in the RORA gene and 6 SNPs in the RORB gene may contribute to the susceptibility for MetS, especially RORA (rs17237367, rs58469372, rs12591650, rs12594188, rs17270446, rs11630062, rs8029848, rs8034880, rs72752802) and RORB rs972902. Our results also suggested an association of high fasting glucose with the RORA rs8029848, RORA rs8034880, and RORB rs972902 SNPs; however, the significance did not persist after adjusting for Bonferroni correction. The proteins encoded by RORA (located on chromosome 15q22.2) and RORB (located on chromosome 9q2) constitute a subfamily of nuclear hormone receptors [40]. The RORA and RORB genes have been implicated in the regulation of a wide variety of physiological processes, including metabolism, circadian rhythm, and inflammatory responses [40, 41]. Kang et al. demonstrated that Rora-deficient mice showed a markedly reduced susceptibility to age- and diet-induced MetS, implicating Rora plays a critical role in the regulation of several aspects of MetS [41].
Previously, circadian clock genes have been reported to associate with MetS, such as a three-marker haplotype (rs4864548, rs3736544, and rs1801260) of the CLOCK gene [7] and CRY2 rs75065406 [8]. In addition, circadian clock genes have been shown to link with the individual components of MetS, including an association of NPAS2 rs11541353 with hypertension [10], an association of PER2 #10870 with high fasting glucose [10], and an association of CRY1 haplotype (rs4964513 and rs12821586) with elevated blood pressure [8]. In this study, we did not weigh CLOCK (rs4864548, rs3736544, and rs1801260), CRY1 (rs4964513 and rs12821586), CRY2 rs75065406, NPAS2 rs11541353, and PER2 #10870 due to lack of these SNPs in the custom chip. It is worth mentioning that the minor allele frequencies of CRY2 rs75065406 and NPAS2 rs11541353 are all 0% in Asian populations (such as Japanese and Han Chinese) as shown in the public data from the 1000 Genomes Project (http://www.1000genomes.org). Moreover, it should be noted that CRY1 (rs4964513 and rs12821586) are annotated within the mitochondrial transcription termination factor 2 (MTERF2) gene, which is in the vicinity of the CRY1 gene, as shown in the dbSNP database (https://www.ncbi.nlm.nih.gov/). On the other hand, we identified other potential candidate SNPs for MetS, including 3 SNPs in the CRY1 gene and 6 SNPs in the NPAS2 gene.
Intriguingly, another finding was that we further inferred the epistatic effects between ARNTL, GSK3B, PER3, RORA, and RORB in influencing MetS by using the GMDR approach. To our knowledge, no other study has been conducted to evaluate gene-gene interactions between these genes. Besides the statistical significance, the potential biological mechanism under the interaction models was our concern. The functional relevance of the interactive effects of ARNTL, GSK3B, PER3, RORA, and RORB on MetS remains to be elucidated. In mammals, the molecular clock mechanism is currently viewed as a complex interplay of transcriptional feedback regulatory loops involving various circadian clock genes to generate and maintain circadian rhythms [40]. The core circadian clock gene ARNTL encodes the ARNTL protein, which is a basic helix-loop-helix protein that forms heterodimers with either CLOCK or NPAS2, two other basic helix-loop-helix proteins [2]. The ARNTL/CLOCK heterodimer initiates the transcription of various target genes such as PER1, PER2, PER3, CRY1, and CRY2 via E-box elements in the promoters of target genes [2]. In turn, the resulting PER and CRY proteins inhibit further ARNTL/CLOCK transcriptional activity, thereby allowing a new cycle to start from a level of low transcriptional activity. In order to improve the robustness of the previous loop, an additional feedback loop involves the nuclear receptors NR1D1 (or Rev-erb alpha)and RORA, which regulate the circadian transcription of the ARNTL gene and provide a good timing of the core clock machinery [40].
Remarkably, the GMDR analysis of gene-environment interactions reflected the interplay among PER3, RORB, and smoking in influencing MetS. Similarly, we tracked down several significant gene-environment interaction models in influencing individual components such as low HDL and high fasting glucose. It has been highlighted that common diseases are known to have a considerable genetic contribution, although only a proportion of complex diseases overall is explained by the established candidate genes, pointing out that environmental effects and gene-environment interactions will be our key concern in the outlook for genomic studies [42].
In terms of the average ages in the MetS and non-MetS groups, subjects with MetS were significantly older than those without MetS in this study (Table 1). Consistent with our results, Hwang et al. reported that the prevalence of MetS in Taiwan increased with age from 5.2% in individuals aged 20–29 to 36.5% in individuals aged 70–79, reaching peak levels in the 7th decade of life for both men and women [43]. Similarly, the prevalence of the MetS increased with age (ranging from about 7% in persons aged 20–29, about 14% in persons aged 30–39, about 20% in persons aged 40–49, to about 44% in persons aged 60–69) in National Health and Nutrition Examination Survey (1988–1994) in the United States [44].
This study has both strengths and limitations. The main weakness was that our observations require much further research to validate whether the findings are replicated in diverse ethnic groups [45–47]. This study may also fail to assess other relevant circadian clock genes such as the basic helix-loop-helix family member e41 (BHLHE41) gene due to lack of those genes in the custom chip. In future work, prospective clinical trials with other ethnic populations are needed to examine a thorough evaluation of the association and interactions of the investigated genes with MetS and its individual components [48, 49]. On the other hand, a major strength of our study was that we employed health-related behavior data, which served an exclusionary opportunity to facilitate the interplay between the investigated genes and environmental factors.
Conclusions
In conclusion, we conducted an extensive analysis of the association as well as gene-gene and gene-environment interactions of the circadian clock genes with MetS and its individual components in Taiwanese subjects. Our findings indicate that the ARNTL, GSK3B, PER3, RORA, and RORB genes may affect the prevalence of MetS independently and/or through complex gene-gene and gene-environment interactions. Furthermore, the circadian clock genes may be a determinant of MetS component factors. Independent replication studies with larger sample sizes will likely demonstrate further insights into the role of the circadian clock genes found in this study.
Supporting information
Acknowledgments
The authors extend their sincere thanks to Vita Genomics, Inc. for this research.
Data Availability
The data underlying this study are available from the Taiwan Biobank Institutional Data Access / Ethics Committee for researchers who meet the criteria for access to confidential data. To apply for access to these third party data please contact the Taiwan Biobank at biobank@gate.sinica.edu.tw. The authors confirm that interested researchers may apply to access these data in the manner described.
Funding Statement
This work was supported by the Ministry of Economic Affairs in Taiwan (http://www.moea.gov.tw/; SBIR Grant S099000280249-154; EL), by Taipei Veterans General Hospital, Taiwan (www.vghtpe.gov.tw/; Grants VGHUST103-G1-4-1, V105C-008, and V105E17-002-MY2-1; SJT), by National Health Research Institutes, Taiwan (www.nhri.org.tw/; Grant NP-105-SP-04; YLL), and by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/; Grant MST 102-2314-B-002-117-MY3; PHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation, Vita Genomics, Inc., provided support in the form of salary for author EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section.
References
- 1.Ribas-Latre A, Eckel-Mahan K. Interdependence of nutrient metabolism and the circadian clock system: Importance for metabolic health. Mol Metab. 2016; 5: 133–52. 10.1016/j.molmet.2015.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Buhr ED, Takahashi JS. Molecular components of the Mammalian circadian clock. Handb Exp Pharmacol. 2013; (217): 3–27. 10.1007/978-3-642-25950-0_1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cagampang FR, Poore KR, Hanson MA. Developmental origins of the metabolic syndrome: body clocks and stress responses. Brain Behav Immun. 2011; 25: 214–20. 10.1016/j.bbi.2010.09.005 [DOI] [PubMed] [Google Scholar]
- 4.Maury E, Hong HK, Bass J. Circadian disruption in the pathogenesis of metabolic syndrome. Diabetes Metab. 2014; 40: 338–46. 10.1016/j.diabet.2013.12.005 [DOI] [PubMed] [Google Scholar]
- 5.Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2004; 2: e377 10.1371/journal.pbio.0020377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005; 308: 1043–5. 10.1126/science.1108750 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Scott EM, Carter AM, Grant PJ. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond). 2008; 32: 658–62. [DOI] [PubMed] [Google Scholar]
- 8.Kovanen L, Donner K, Kaunisto M, Partonen T. CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome. Hypertens Res. 2015; 38: 186–92. 10.1038/hr.2014.157 [DOI] [PubMed] [Google Scholar]
- 9.Woon PY, Kaisaki PJ, Bragança J, Bihoreau MT, Levy JC, Farrall M, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A. 2007; 104: 14412–7. 10.1073/pnas.0703247104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Englund A, Kovanen L, Saarikoski ST, Haukka J, Reunanen A, Aromaa A, et al. NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J Circadian Rhythms. 2009; 7: 5 10.1186/1740-3391-7-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gómez-Abellán P, Hernández-Morante JJ, Luján JA, Madrid JA, Garaulet M. Clock genes are implicated in the human metabolic syndrome. Int J Obes (Lond). 2008; 32: 121–8. [DOI] [PubMed] [Google Scholar]
- 12.Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010; 466: 627–31. 10.1038/nature09253 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shimba S, Ogawa T, Hitosugi S, Ichihashi Y, Nakadaira Y, Kobayashi M, et al. Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS One. 2011; 6: e25231 10.1371/journal.pone.0025231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Costa MJ, So AY, Kaasik K, Krueger KC, Pillsbury ML, Fu YH, et al. Circadian rhythm gene period 3 is an inhibitor of the adipocyte cell fate. J Biol Chem. 2011; 286: 9063–70. 10.1074/jbc.M110.164558 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gonzalez R, Gonzalez S, Villa E, Ramirez M, Zavala J, Armas R, et al. Identification of circadian gene variants in bipolar disorder in Latino populations. J Affect Disord. 2015; 186: 367–75. 10.1016/j.jad.2015.07.014 [DOI] [PubMed] [Google Scholar]
- 16.Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res. 2015; 2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lin E, Kuo PH, Liu YL, Yang AC, Kao CF, Tsai SJ. Effects of circadian clock genes and environmental factors on cognitive aging in old adults in a Taiwanese population. Oncotarget. 2017; Forthcoming. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Shakes LA, Du H, Wolf HM, Hatcher C, Norford DC, Precht P, et al. Using BAC transgenesis in zebrafish to identify regulatory sequences of the amyloid precursor protein gene in humans. BMC Genomics. 2012; 13: 451 10.1186/1471-2164-13-451 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, et al. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009; 11: 701–10. 10.1111/j.1399-5618.2009.00756.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Liu AC, Tran HG, Zhang EE, Priest AA, Welsh DK, Kay SA. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 2008; 4: e1000023 10.1371/journal.pgen.1000023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wang H, Chu W, Das SK, Zheng Z, Hasstedt SJ, Elbein SC. Molecular screening and association studies of retinoid-related orphan receptor gamma (RORC): a positional and functional candidate for type 2 diabetes. Mol Genet Metab. 2003; 79: 176–82. [DOI] [PubMed] [Google Scholar]
- 22.Fan CT, Lin JC, Lee CH. Taiwan Biobank: a project aiming to aid Taiwan's transition into a biomedical island. Pharmacogenomics. 2008; 9: 235–46. 10.2217/14622416.9.2.235 [DOI] [PubMed] [Google Scholar]
- 23.Lin E, Kuo PH, Liu YL, Yang AC, Kao CF, Tsai SJ. Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population. Sci Rep. 2016; 6: 36830 10.1038/srep36830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Chen CH, Yang JH, Chiang CW, Hsiung CN, Wu PE, Chang LC, et al. Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet. 2016. [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lin E, Tsai SJ, Kuo PH, Liu YL, Yang AC, Kao CF, Yang CH. The rs1277306 variant of the REST gene confers susceptibility to cognitive aging in the elderly in a Taiwanese population. Dement Geriatr Cogn Disord. 2016; 43: 119–127. [DOI] [PubMed] [Google Scholar]
- 26.Lin E, Tsai SJ, Kuo PH, Liu YL, Yang AC, Kao CF. Association and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population. Oncotarget. 2017; Forthcoming. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lin E, Tsai SJ, Kuo PH, Liu YL, Yang AC, Kao CF, Yang CH. The ADAMTS9 gene is associated with cognitive aging in the elderly in a Taiwanese population. PLoS One. 2017; Forthcoming. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Liou YJ, Bai YM, Lin E, Chen JY, Chen TT, Hong CJ, et al. Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics. Pharmacogenomics J. 2012; 12: 54–61 [DOI] [PubMed] [Google Scholar]
- 29.Hsiao TJ, Lin E. The ENPP1 K121Q polymorphism is associated with type 2 diabetes and related metabolic phenotypes in a Taiwanese population. Mol Cell Endocrinol. 2016; 433: 20–25. 10.1016/j.mce.2016.05.020 [DOI] [PubMed] [Google Scholar]
- 30.Hsiao TJ, Lin E. The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population. Endocrine. 2015; 48: 786–93. 10.1007/s12020-014-0407-7 [DOI] [PubMed] [Google Scholar]
- 31.Hsiao TJ, Hwang Y, Liu CH, Chang HM, Lin E. Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population. Genes Nutr. 2013; 8: 137–44. 10.1007/s12263-012-0304-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100: 9440–5. 10.1073/pnas.1530509100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007; 80: 1125–1137. 10.1086/518312 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lane HY, Tsai GE, Lin E. Assessing gene-gene interactions in pharmacogenomics. Mol Diagn Ther. 2012; 16: 15–27. [DOI] [PubMed] [Google Scholar]
- 35.Kaidanovich-Beilin O, Woodgett JR. GSK-3: Functional Insights from Cell Biology and Animal Models. Front Mol Neurosci. 2011; 4: 40 10.3389/fnmol.2011.00040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chen H, Fajol A, Hoene M, Zhang B, Schleicher ED, Lin Y, et al. PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome. Proc Natl Acad Sci U S A. 2016; 113: 5754–9. 10.1073/pnas.1601355113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Marcheva B, Ramsey KM, Peek CB, Affinati A, Maury E, Bass J. Circadian clocks and metabolism. Handb Exp Pharmacol. 2013; 217: 127–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Dallmann R, Weaver DR. Altered body mass regulation in male mPeriod mutant mice on high-fat diet. Chronobiol Int. 2010; 27: 1317–28. 10.3109/07420528.2010.489166 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pendergast JS, Niswender KD, Yamazaki S. Tissue-specific function of Period3 in circadian rhythmicity. PLoS One. 2012; 7: e30254 10.1371/journal.pone.0030254 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Duez H, Staels B. Rev-erb-alpha: an integrator of circadian rhythms and metabolism. J Appl Physiol (1985). 2009; 107: 1972–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kang HS, Okamoto K, Takeda Y, Beak JY, Gerrish K, Bortner CD, et al. Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis. Physiol Genomics. 2011; 43: 818–28. 10.1152/physiolgenomics.00206.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lee SH, Harold D, Nyholt DR; ANZGene Consortium; International Endogene Consortium; Genetic and Environmental Risk for Alzheimer's disease Consortium, Goddard ME, Zondervan KT, Williams J, et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Hum Mol Genet. 2013; 22:832–41. 10.1093/hmg/dds491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006; 105: 626–35. 10.1016/S0929-6646(09)60161-3 [DOI] [PubMed] [Google Scholar]
- 44.Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287: 356–9. [DOI] [PubMed] [Google Scholar]
- 45.Hsiao TJ, Hwang Y, Chang HM, Lin E. Association of the rs6235 variant in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene with obesity and related traits in a Taiwanese population. Gene. 2014; 533: 32–7. 10.1016/j.gene.2013.10.016 [DOI] [PubMed] [Google Scholar]
- 46.Hsiao TJ, Lin E. A common rs7903146 variant of the transcription factor 7 like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population. Diabetes Metab. 2017; 43: 83–85. 10.1016/j.diabet.2016.05.003 [DOI] [PubMed] [Google Scholar]
- 47.Hsiao TJ, Lin E. Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor beta 2 surface gene on obesity and metabolic phenotypes in Taiwan. J Investig Med. 2014; 62: 310–5. 10.2310/JIM.0000000000000030 [DOI] [PubMed] [Google Scholar]
- 48.Hsiao TJ, Lin E. Association of a common rs9939609 variant in the fat mass and obesity-associated (FTO) gene with obesity and metabolic phenotypes in a Taiwanese population: a replication study. J Genet. 2016; 95: 595–601. [DOI] [PubMed] [Google Scholar]
- 49.Hsiao TJ, Lin E. A validation study of adiponectin rs266729 gene variant with type 2 diabetes, obesity, and metabolic phenotypes in a Taiwanese population. Biochem Genet. 2016; 54: 830–841. 10.1007/s10528-016-9760-y [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data underlying this study are available from the Taiwan Biobank Institutional Data Access / Ethics Committee for researchers who meet the criteria for access to confidential data. To apply for access to these third party data please contact the Taiwan Biobank at biobank@gate.sinica.edu.tw. The authors confirm that interested researchers may apply to access these data in the manner described.